These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 703677)

  • 1. [The effects of atenolol on the heart size, on the heart rate, and on the blood pressure at rest (author's transl)].
    Frisch P
    Med Klin; 1978 Oct; 73(42):1477-80. PubMed ID: 703677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long term comparison between atenolol and a depot form of propranolol hydrochloride on the heart rate and blood pressure at rest and during physical work in normal subjects].
    Wink K; Weisser P
    Arzneimittelforschung; 1980; 30(8):1298-301. PubMed ID: 7192146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of atenolol on contractility and hemodynamics of the infarcted heart in comparison to propranolol and practolol (author's transl)].
    Stephan K; Meesmann W; Bischoff KO; Hübner H; Geigenmüller L; Diesch J
    Arzneimittelforschung; 1975 Nov; 25(11):1770-6. PubMed ID: 1243085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The hypertensive heart. VII. Effect of atenolol on the function, coronary haemodynamics and oxygen uptake of the left ventricle (author's transl)].
    Strauer BE
    Dtsch Med Wochenschr; 1978 Nov; 103(45):1785-9. PubMed ID: 710288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long term effects of the beta-adrenergic blocking agent atenolol (Tenormin) on coronary heart disease: a study of 125 patients (author's transl)].
    Langbehn AF; Burmeister G; Horst H; Sonntag F; Klempien EJ
    Med Klin; 1978 Jan; 73(3):101-5. PubMed ID: 622059
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of antihypertensive activity of atenolol and methyldopa at rest and during exercise.
    Magnani B; Ambrosioni E; Costa FV; Malini PL; Magelli C
    Int J Clin Pharmacol Ther Toxicol; 1981 Oct; 19(10):440-4. PubMed ID: 7287240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ambulatory blood pressure and heart rate during once-daily, randomized, crossover administration of carteolol and atenolol.
    Saito K; Furuta Y; Sano H; Yokoyama M; Fukuzaki H
    Clin Ther; 1994; 16(2):181-90. PubMed ID: 8062314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of a new cardioselective beta-adrenergic blocker (atenolol) on airway resistance in chronic obstructive disease (author's transl)].
    Beil M; Ulmer WT
    Arzneimittelforschung; 1977 Feb; 27(2):419-22. PubMed ID: 324487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation by exercise test of effects of a single oral dose of atenolol in patients with stable angina (author's transl)].
    de Divitiis O; de Simone G; Maddalena G; Castaldo M; Ruggiano A
    G Ital Cardiol; 1981; 11(12):2088-96. PubMed ID: 7049818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atenolol in the treatment of premature ventricular contractions. A double blind study in 68 patients (author's transl)].
    Körst HA; Brandes JW; Lembcke HJ; Littmann KP
    Z Kardiol; 1981 May; 70(5):419-24. PubMed ID: 6168124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
    Sourgens H; Schmidt J; Derendorf H
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tokolysis and dose-dependent effects of beta-blocking with atenolol in the rabbit].
    Steib L; Czekelius P; Behr J
    Z Geburtshilfe Perinatol; 1982; 186(3):145-9. PubMed ID: 6889791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different hemodynamic effects of celipropol and atenolol in patients with mild to moderate hypertension.
    Saner H; Seiler A; Mahler F
    Arzneimittelforschung; 1995 Jul; 45(7):790-5. PubMed ID: 8573224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of monotherapy with an alpha1-adrenoblocker doxazosin and its combination with beta1-adrenoblocker atenolol on hemodynamics, reversible myocardial ischemia in postmyocardial infarction patients with arterial hypertension].
    Tepliakov AT; Gavrilova NV; Garganeeva AA
    Klin Med (Mosk); 2003; 81(11):17-21. PubMed ID: 14689703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of atenolol in moderate arterial hypertension. Evaluation by stress test].
    Arrieta JA; Alegría E; Huguet R; Larraz MP; Calabuig J; Martínez Caro D
    Rev Med Univ Navarra; 1987; 31(1):23-8. PubMed ID: 3616360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of pretreatment with atenolol and propranolol on sympatho-adrenal and cardiovascular responses to acute insulin-induced hypoglycaemia in the hypertensive patient].
    Cannella G; Picotti GB; Giambelli A; Scolari F; Cesura AM; Tosoni S; Maiorca R
    G Ital Cardiol; 1982; 12(12):884-8. PubMed ID: 6763907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents?
    Leonetti G; Sampieri L; Cuspidi C; Terzoli L; Rupoli L; Fruscio M; Gradnik R; Zanchetti A
    J Hypertens Suppl; 1985 Dec; 3(3):S243-5. PubMed ID: 2908819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The demonstration of atenolol as a beta-adrenoceptor blocking drug in man.
    Harry JD
    Postgrad Med J; 1977; 53 Suppl 3():65-9. PubMed ID: 928268
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.